Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Shares Issued
Ratios

SELLAS Life Sciences (SLS) Cost of Revenue (2021 - 2022)

SELLAS Life Sciences (SLS) has disclosed Cost of Revenue for 2 consecutive years, with $100000.0 as the latest value for Q1 2022.

  • Quarterly Cost of Revenue changed 0.0% to $100000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $100000.0 through Dec 2022, down 50.0% year-over-year, with the annual reading at $100000.0 for FY2022, 50.0% down from the prior year.
  • Cost of Revenue for Q1 2022 was $100000.0 at SELLAS Life Sciences, roughly flat from $100000.0 in the prior quarter.
  • The five-year high for Cost of Revenue was $100000.0 in Q1 2021, with the low at $100000.0 in Q1 2021.